BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 24966156)

  • 1. Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study.
    Kim HY; Kim H; Oh KW; Oh SI; Koh SH; Baik W; Noh MY; Kim KS; Kim SH
    Stem Cells; 2014 Oct; 32(10):2724-31. PubMed ID: 24966156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
    Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
    Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
    Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
    JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural induction with neurogenin 1 enhances the therapeutic potential of mesenchymal stem cells in an amyotrophic lateral sclerosis mouse model.
    Chan-Il C; Young-Don L; Heejaung K; Kim SH; Suh-Kim H; Kim SS
    Cell Transplant; 2013; 22(5):855-70. PubMed ID: 22472631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-PIX is critical for transplanted mesenchymal stromal cell migration.
    Koh SH; Huh YM; Noh MY; Kim HY; Kim KS; Lee ES; Ko HJ; Cho GW; Yoo AR; Song HT; Hwang S; Lee K; Haam S; Frank JA; Suh JS; Kim SH
    Stem Cells Dev; 2012 Jul; 21(11):1989-99. PubMed ID: 22087847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
    Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
    Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis.
    Boido M; Piras A; Valsecchi V; Spigolon G; Mareschi K; Ferrero I; Vizzini A; Temi S; Mazzini L; Fagioli F; Vercelli A
    Cytotherapy; 2014 Aug; 16(8):1059-72. PubMed ID: 24794182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate.
    Koh SH; Baik W; Noh MY; Cho GW; Kim HY; Kim KS; Kim SH
    Exp Neurol; 2012 Jan; 233(1):472-80. PubMed ID: 22119626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
    Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
    Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
    Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
    Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells.
    Nicaise C; Mitrecic D; Pochet R
    Neuropathol Appl Neurobiol; 2011 Feb; 37(2):179-88. PubMed ID: 20846186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
    Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
    Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis.
    Siwek T; Jezierska-Woźniak K; Maksymowicz S; Barczewska M; Sowa M; Badowska W; Maksymowicz W
    Med Sci Monit; 2020 Dec; 26():e927484. PubMed ID: 33301428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
    Oh KW; Noh MY; Kwon MS; Kim HY; Oh SI; Park J; Kim HJ; Ki CS; Kim SH
    Ann Neurol; 2018 Sep; 84(3):361-373. PubMed ID: 30048006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
    Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
    Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels.
    Choi M; Lee HS; Naidansaren P; Kim HK; O E; Cha JH; Ahn HY; Yang PI; Shin JC; Joe YA
    Int J Biochem Cell Biol; 2013 Mar; 45(3):560-70. PubMed ID: 23246593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus.
    Rushkevich YN; Kosmacheva SM; Zabrodets GV; Ignatenko SI; Goncharova NV; Severin IN; Likhachev SA; Potapnev MP
    Bull Exp Biol Med; 2015 Aug; 159(4):576-81. PubMed ID: 26395626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study.
    Prabhakar S; Marwaha N; Lal V; Sharma RR; Rajan R; Khandelwal N
    Neurol India; 2012; 60(5):465-9. PubMed ID: 23135021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?
    Allers C; Jones JA; Lasala GP; Minguell JJ
    Regen Med; 2014; 9(5):637-47. PubMed ID: 25372079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.